New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
MariMed Inc.
MRMD
Shape
US Flag

PNK

Unprofitable

Unprofitable

64M

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

64M

Drug Manufacturers - Specialty & Generic

Next Earning date - 06 Nov 2024

0.17USD
Shape-0.00 ( -0.59%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-32%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

56%

Quote Panel

Shape
Updated October 24, 2024
1W 4.97 % 1M -1.66 % 3M -0.47 % 1Y -51.44 %

Key Metrics

Shape
  • Market Cap

    64.32M


  • Shares Outstanding

    380.61M


  • Share in Float

    341.76M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    0.169


  • Average Volume

    464757


  • Beta

    2.8


  • Range

    0.138-0.387


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.marimedinc.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.41x

P/S Ratio

0.91x

P/B Ratio

1.4

Debt/Equity

-11.1%

Net Margin

$-0.1

EPS

How MRMD compares to sector?

P/E Ratio

Relative Strength

Shape

MRMD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$183M

Shape352%

2025-Revenue

$0.01

Shape-241%

2025-EPS

$20M

Shape397%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

0.01
vs 0.01

Q4.22

arrow
arrow

+150%

0.01
vs -0.02

Q1.23

arrow
arrow

N/A

-0.00
vs 0.01

Q2.23

arrow
arrow

N/A

-0.00
vs 0

Q3.23

arrow
arrow

N/A

-0.01
vs 0.01

Q4.23

arrow
arrow

N/A

-0.03
vs 0.01

Q1.24

arrow
arrow

N/A

-0.00
vs -0.00

Q2.24

arrow
arrow

N/A

-0.00
vs -0.00

Q3.24

arrow
arrow

N/A

-0.01
vs -0.01

Q4.24

arrow
arrow

N/A

-0.01
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+2%

33.9M  vs 33.2M

Q4.22

arrow
arrow

+15%

35.8M  vs 31M

Q1.23

arrow
arrow

+10%

34.4M  vs 31.3M

Q2.23

arrow
arrow

+11%

36.5M  vs 33M

Q3.23

arrow
arrow

+14%

38.8M  vs 33.9M

Q4.23

arrow
arrow

+9%

38.9M  vs 35.8M

Q1.24

arrow
arrow

+10%

37.9M  vs 34.4M

Q2.24

arrow
arrow

+11%

40.4M  vs 36.5M

Q3.24

arrow
arrow

+7%

41.6M  vs 38.8M

Q4.24

arrow
arrow

+11%

43M  vs 38.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.04

Q4.22

arrow
arrow

+8%

0.08
vs 0.05

Q1.23

arrow
arrow

-1%

-0.01
vs 0.08

Q2.23

arrow
arrow

-1%

-0.01
vs -0.01

Q3.23

arrow
arrow

-5%

-0.05
vs -0.01

Q4.23

arrow
arrow

-14%

-0.14
vs -0.05

Q1.24

arrow
arrow

-2%

-0.02
vs -0.14

Q2.24

arrow
arrow

-2%

-0.02
vs -0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

4

4
vs 7

-43%

Q4.22

arrow
arrow

4

4
vs 4

NA

Q1.23

arrow
arrow

3

3
vs 4

-25%

Q2.23

arrow
arrow

4

4
vs 3

33%

Q3.23

arrow
arrow

2

2
vs 4

-50%

Q4.23

arrow
arrow

3

3
vs 2

50%

Q1.24

arrow
arrow

3

3
vs 3

NA

Q2.24

arrow
arrow

3

3
vs 3

NA

Earnings Growth

Latest News